login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
UNITED THERAPEUTICS CORP (UTHR) Stock News
USA
- NASDAQ:UTHR -
US91307C1027
-
Common Stock
408.85
USD
+5.17 (+1.28%)
Last: 9/18/2025, 3:20:07 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
UTHR Latest News, Press Relases and Analysis
All
Press Releases
a day ago - By: Chartmill
United Therapeutics Corp (NASDAQ:UTHR) Emerges as a Top Peter Lynch-Style GARP Investment
12 days ago - By: Chartmill
United Therapeutics Corp (NASDAQ:UTHR): A Prime Value Investing Candidate with Strong Fundamentals
2 days ago - By: United Therapeutics Corporation
United Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum
6 days ago - By: United Therapeutics Corporation
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the European Respiratory Society Congress
9 days ago - By: Investor's Business Daily
- Mentions:
AUPH
HALO
ARGX
United Therapeutics Price Strength Rating Jumps After Its Stock Soared 33% Last Week On Positive Drug Test Results
11 days ago - By: Benzinga
- Mentions:
IOT
CIEN
EXAS
SATS
...
Wayfair, United Therapeutics, And Ciena Are Among The Top 10 Large-Cap Gainers Last Week (July 14-July 18): Are The Others In Your Portfolio?
15 days ago - By: Zacks Investment Research
- Mentions:
INSM
LQDA
UTHR Stock Hits Record High on Tyvaso Meeting IPF Study Goals
15 days ago - By: Yahoo Finance
- Mentions:
DB
PEP
STZ
SIG
...
Morning Movers: United Therapeutics surges after TETON-2 met primary endpoint
16 days ago - By: Stocktwits
- Mentions:
MNKD
MannKind Lands A Price-Target Hike After Partner United Therapeutics Reports Strong Lung Drug Trial Results
16 days ago - By: Chartmill
- Mentions:
CYTK
IONS
PPBT
CELU
...
Here are the top movers in Tuesday's session.
16 days ago - By: Benzinga
- Mentions:
CYTK
CGC
ALTS
RLMD
...
12 Health Care Stocks Moving In Tuesday's Intraday Session
16 days ago - By: Stocktwits
- Mentions:
AVUS
DRUP
This Pharma Stock Soared 36% Today And Drew Price Target Hikes From Wall Street – More Details Inside
16 days ago - By: Chartmill
- Mentions:
CYTK
ASNS
PPBT
CELU
...
Top movers analysis in the middle of the day on 2025-09-02: top gainers and losers in today's session.
16 days ago - By: Chartmill
- Mentions:
CYTK
MNKD
IONS
SSKN
...
There are notable gap-ups and gap-downs in today's session.
16 days ago - By: Investor's Business Daily
- Mentions:
INSM
LQDA
Why United Therapeutics Just Catapulted 35%, Pulling Insmed, Liquidia With It
16 days ago - By: Chartmill
- Mentions:
CYTK
MNKD
MOVE
IPDN
...
Tuesday's pre-market session: top gainers and losers
16 days ago - By: United Therapeutics Corporation
United Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso® Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis
20 days ago - By: Zacks Investment Research
Why Is United Therapeutics (UTHR) Up 11.9% Since Last Earnings Report?
20 days ago - By: United Therapeutics Corporation
United Therapeutics Corporation to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
22 days ago - By: Stocktwits
- Mentions:
MNKD
MannKind, United Therapeutics Expand Agreement To Develop A Second Investigational Molecule Together
a month ago - By: Investor's Business Daily
- Mentions:
LQDA
Liquidia Shoots Higher, But At-Risk Launch Could Come Back To Haunt It
a month ago - By: Zacks Investment Research
- Mentions:
JNJ
MRK
VRNA
Merck's Narrowed 2025 Sales View: What it Means After Q2 Results?
Please enable JavaScript to continue using this application.